Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis
Clinical trial NCT00630279 · TERMINATED
Trial details
- NCT number
- NCT00630279
- Sponsor
- Solvay Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-03-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.